 |
Discovering, developing and commercializing cancer therapeutics. |
Public |
2003 |
View Profile |
 |
Novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. |
Public |
2000 |
View Profile |
 |
Innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests. |
Public |
2003 |
View Profile |
 |
Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. |
Public |
2002 |
View Profile |
 |
Developing therapeutic candidates for the treatment of immune and metabolic diseases. |
Public |
2009 |
View Profile |
 |
Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. |
Public |
2006 |
View Profile |
 |
Discovery, development and commercialization of prescription pain management products |
Public |
1996 |
View Profile |
 |
Pharmaceuticals for treatment of metabolic diseases and endocrine disorders |
Public |
1996 |
View Profile |
 |
Products that enhance the ability of veterinarians to economically provide advanced medical care |
Public |
1991 |
View Profile |
 |
Design, development, manufacturing, and marketing of medical devices focused on women's health |
Public |
1989 |
View Profile |
 |
Technology and products to treat cancers, infectious diseases, and autoimmune disorders |
Public |
1994 |
View Profile |
 |
Sequenced human genome; now focused on therapeutics for cancer and other diseases |
Public |
1998 |
View Profile |
 |
Proprietary technologies for the early detection, monitoring and staging of common cancers |
Public |
1995 |
View Profile |
 |
Discovery, development and commercialization of druts to treat neurological diseases and disorders |
Public |
2000 |
View Profile |
 |
Software and services used by brands to dramatically improve their innovation and marketing success rate. |
Private |
2000 |
View Profile |
 |
Discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. |
Private |
2007 |
View Profile |
 |
Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. |
Private |
2006 |
View Profile |
 |
Capitalizing on the global abundance of waste CO2 to economically produce renewable fuels and chemicals. |
Private |
2007 |
View Profile |
_0.jpg) |
Technology leader in the commercial development of a growing portfolio of sustainable products to meet the needs of chemical and fuel markets worldwide. |
Private |
2005 |
View Profile |
 |
Developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. |
Private |
2008 |
View Profile |
